Matches in SemOpenAlex for { <https://semopenalex.org/work/W2564061383> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W2564061383 abstract "In previous study, we have evaluated the ability of histopathologic response criteria to predict overall survival (OS) and disease free survival (DFS) and observed that the percentage of residual viable tumor cells were associated with OS and DFS in 192 NSCLC patients receiving neoadjuvant chemotherapy. In current study, we examined the selected protein biomarkers by IHC in surgical specimens of 98 NSCLC patients receiving neoadjuvant chemotherapy. All NSCLC patients treated with neoadjuvant chemotherapy received a platinum and taxane-based. For IHC analysis of protein markers, we selected candidate biomarkers (VEGFR2, EZH2, ERCC1 and Rad51) on the basis of the literature. Next, the results of VEGFR2, EZH2, ERCC1 and Rad51 expression were analyzed with regard to pathologic response and overall survival time of the patients. The surgical pathologic stage, percentage of viable tumor cells and Rad51 were associated with OS in 98 NSCLC patients receiving neoadjuvant chemotherapy in univariate and multivariate analysis. We found that patients with high-level expression of Rad51 had a poorer prognosis than did those with low-level expression. We observed that Rad51 expression was associated with pathologic response (viable tumor cells). However, there is no association between VEGFR2, EZH2, or ERCC1 expression and pathologic response (viable tumor cells). We further examined K-Ras and EGFR Mutation in these NSCLC tumors receiving neoadjuvant chemotherapy. We analyzed the hotsport mutations in K-Ras gene (Codon 12 and 13) and EGFR gene (Exon 19 and 21) by pyrosequencing and confirmed by direct sequencing method in 98 NSCLC tumors receiving neoadjuvant chemotherapy. We observed both methods had similar results on these patients’ samples. The L858R mutation results in an amino acid substitution at position 858 in EGFR, from a leucine (L) to an arginine (R). This mutation occurs within exon 21, which encodes part of the kinase domain,We found K-Ras mutation tended to be associated with OS, but not EGFR mutation. There is no association between percentage of viable tumor cells, VEGFR2, EZH2, ERCC1, Rad51 expression and K-Ras or EGFR mutation. Citation Format: Apar Pataer, Ruping Shao, Arlene M. Correa, Carmen Behrens, Jack A. Roth, Ignacio I. Wistuba, Stephen G. Swisher. Evaulate biomarkers in NSCLC tumors receiving neoadjuvant chemotherapy. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 1908. doi:10.1158/1538-7445.AM2015-1908" @default.
- W2564061383 created "2017-01-06" @default.
- W2564061383 creator A5009105122 @default.
- W2564061383 creator A5027152610 @default.
- W2564061383 creator A5028085268 @default.
- W2564061383 creator A5041501326 @default.
- W2564061383 creator A5048488308 @default.
- W2564061383 creator A5076621000 @default.
- W2564061383 creator A5076776803 @default.
- W2564061383 date "2015-08-01" @default.
- W2564061383 modified "2023-09-28" @default.
- W2564061383 title "Abstract 1908: Evaulate biomarkers in NSCLC tumors receiving neoadjuvant chemotherapy" @default.
- W2564061383 doi "https://doi.org/10.1158/1538-7445.am2015-1908" @default.
- W2564061383 hasPublicationYear "2015" @default.
- W2564061383 type Work @default.
- W2564061383 sameAs 2564061383 @default.
- W2564061383 citedByCount "0" @default.
- W2564061383 crossrefType "proceedings-article" @default.
- W2564061383 hasAuthorship W2564061383A5009105122 @default.
- W2564061383 hasAuthorship W2564061383A5027152610 @default.
- W2564061383 hasAuthorship W2564061383A5028085268 @default.
- W2564061383 hasAuthorship W2564061383A5041501326 @default.
- W2564061383 hasAuthorship W2564061383A5048488308 @default.
- W2564061383 hasAuthorship W2564061383A5076621000 @default.
- W2564061383 hasAuthorship W2564061383A5076776803 @default.
- W2564061383 hasConcept C104317684 @default.
- W2564061383 hasConcept C104451858 @default.
- W2564061383 hasConcept C121608353 @default.
- W2564061383 hasConcept C126322002 @default.
- W2564061383 hasConcept C134935766 @default.
- W2564061383 hasConcept C142724271 @default.
- W2564061383 hasConcept C143998085 @default.
- W2564061383 hasConcept C144301174 @default.
- W2564061383 hasConcept C204232928 @default.
- W2564061383 hasConcept C2776694085 @default.
- W2564061383 hasConcept C2778292576 @default.
- W2564061383 hasConcept C2779012473 @default.
- W2564061383 hasConcept C2779309665 @default.
- W2564061383 hasConcept C38180746 @default.
- W2564061383 hasConcept C530470458 @default.
- W2564061383 hasConcept C55493867 @default.
- W2564061383 hasConcept C71924100 @default.
- W2564061383 hasConcept C86803240 @default.
- W2564061383 hasConceptScore W2564061383C104317684 @default.
- W2564061383 hasConceptScore W2564061383C104451858 @default.
- W2564061383 hasConceptScore W2564061383C121608353 @default.
- W2564061383 hasConceptScore W2564061383C126322002 @default.
- W2564061383 hasConceptScore W2564061383C134935766 @default.
- W2564061383 hasConceptScore W2564061383C142724271 @default.
- W2564061383 hasConceptScore W2564061383C143998085 @default.
- W2564061383 hasConceptScore W2564061383C144301174 @default.
- W2564061383 hasConceptScore W2564061383C204232928 @default.
- W2564061383 hasConceptScore W2564061383C2776694085 @default.
- W2564061383 hasConceptScore W2564061383C2778292576 @default.
- W2564061383 hasConceptScore W2564061383C2779012473 @default.
- W2564061383 hasConceptScore W2564061383C2779309665 @default.
- W2564061383 hasConceptScore W2564061383C38180746 @default.
- W2564061383 hasConceptScore W2564061383C530470458 @default.
- W2564061383 hasConceptScore W2564061383C55493867 @default.
- W2564061383 hasConceptScore W2564061383C71924100 @default.
- W2564061383 hasConceptScore W2564061383C86803240 @default.
- W2564061383 hasLocation W25640613831 @default.
- W2564061383 hasOpenAccess W2564061383 @default.
- W2564061383 hasPrimaryLocation W25640613831 @default.
- W2564061383 hasRelatedWork W1985818784 @default.
- W2564061383 hasRelatedWork W1990973204 @default.
- W2564061383 hasRelatedWork W2001829326 @default.
- W2564061383 hasRelatedWork W2018316466 @default.
- W2564061383 hasRelatedWork W2083756742 @default.
- W2564061383 hasRelatedWork W2094644910 @default.
- W2564061383 hasRelatedWork W2139178091 @default.
- W2564061383 hasRelatedWork W2169852451 @default.
- W2564061383 hasRelatedWork W2352535670 @default.
- W2564061383 hasRelatedWork W2374008788 @default.
- W2564061383 hasRelatedWork W2380101453 @default.
- W2564061383 hasRelatedWork W2736766328 @default.
- W2564061383 hasRelatedWork W2739852565 @default.
- W2564061383 hasRelatedWork W2774070429 @default.
- W2564061383 hasRelatedWork W2802047808 @default.
- W2564061383 hasRelatedWork W2809550065 @default.
- W2564061383 hasRelatedWork W2885580860 @default.
- W2564061383 hasRelatedWork W2903268078 @default.
- W2564061383 hasRelatedWork W3183882835 @default.
- W2564061383 hasRelatedWork W3208984379 @default.
- W2564061383 isParatext "false" @default.
- W2564061383 isRetracted "false" @default.
- W2564061383 magId "2564061383" @default.
- W2564061383 workType "article" @default.